Last 12 months
Inside the activity.
1 purchase rows · 6 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 1 | 2 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 10, 2024 Filed Jan 16, 2024 21:42 UTC |
Shukla Abhinav A.Chief Technical Officer
|
GrantStock Option (Right to Buy) · Derivative | 66,850 | $0.00 Strike: $10.09 | $0.00 |
DisclosureSEC source: 0000950170-24-004670 · ownership.xml · derivative · entry 2 Shukla Abhinav A. · CIK 0001923377 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,850 Underlying: Common Stock · 66,850 shares Expires 2034-01-10 F3 · derivative.exercise_date: This option represents a right to purchase a total of 66,850 shares of the Issuer's common stock, one quarter of which will vest on January 10, 2025, with the remaining three quarters vesting in equal monthly installments through January 10, 2028, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| January 10, 2024 Filed Jan 16, 2024 21:42 UTC |
Shukla Abhinav A.Chief Technical Officer
|
GrantCommon Stock | 33,425 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-004670 · ownership.xml · nonDerivative · entry 1 Shukla Abhinav A. · CIK 0001923377 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,717 F1 · shares: Consists of 33,425 restricted stock units, which will vest in four equal annual installments beginning on January 10, 2025, subject to the Reporting Person's continued service to the Issuer. F2 · balance_after: Includes 600 shares acquired by the Reporting Person under the Issuer's 2020 Employee Stock Purchase Plan on each of February 14, 2023 and August 14, 2023. Read SEC document |
| January 10, 2024 Filed Jan 16, 2024 21:35 UTC |
Neill Andrew RChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 113,000 | $0.00 Strike: $10.09 | $0.00 |
DisclosureSEC source: 0000950170-24-004656 · ownership.xml · derivative · entry 4 Neill Andrew R · CIK 0001827204 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 113,000 Underlying: Common Stock · 113,000 shares Expires 2034-01-10 F2 · derivative.exercise_date: This option represents a right to purchase a total of 113,000 shares of the Issuer's common stock, one quarter of which will vest on January 10, 2025, with the remaining three quarters vesting in equal monthly installments through January 10, 2028, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| January 10, 2024 Filed Jan 16, 2024 21:35 UTC |
Neill Andrew RChief Financial Officer
|
SaleCommon Stock | 25,000 | $10.00 | $250,000.00 |
DisclosureSEC source: 0000950170-24-004656 · ownership.xml · nonDerivative · entry 3 Neill Andrew R · CIK 0001827204 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 173,446 Read SEC document |
| January 10, 2024 Filed Jan 16, 2024 21:35 UTC |
Neill Andrew RChief Financial Officer
|
Tax withholdingCommon Stock | 2,470 | $10.09 | $24,922.30 |
DisclosureSEC source: 0000950170-24-004656 · ownership.xml · nonDerivative · entry 2 Neill Andrew R · CIK 0001827204 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 198,446 Read SEC document |
| January 10, 2024 Filed Jan 16, 2024 21:35 UTC |
Neill Andrew RChief Financial Officer
|
GrantCommon Stock | 56,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-004656 · ownership.xml · nonDerivative · entry 1 Neill Andrew R · CIK 0001827204 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 200,916 F1 · shares: Consists of 56,500 restricted stock units, which will vest in four equal annual installments beginning on January 10, 2025, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| December 21, 2023 Filed Dec 27, 2023 02:30 UTC |
Redmile Group, LLCDirector · 10% owner
Green JeremyDirector · 10% owner
|
GrantPre-Funded Warrant to Purchase Common Stock · Derivative | 3,100,823 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001104659-23-129340 · tm2333671-2_4seq1.xml · derivative · entry 1 Redmile Group, LLC · CIK 0001425738 · Director · 10% owner Green Jeremy · CIK 0001650527 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 3,100,823 Underlying: Common Stock · 3,100,823 shares Expires not disclosed F1 · security: On December 21, 2023, the Issuer entered into a securities purchase agreement (the "Purchase Agreement") with certain private investment vehicles and sub-advised accounts managed by Redmile Group, LLC (collectively, the "Redmile Funds"). Pursuant to the terms of the Purchase Agreement, the Issuer in a private placement, which closed on the second trading day following the date of the Purchase Agreement, issued and sold to the Redmile Funds pre-funded warrants (the "Warrants") to purchase up to an aggregate of 3,100,823 shares of the Issuer's common stock (the "Warrant Shares") at a purchase price per share equal to $6.4499, which represents the offering price per share of the Common Stock less the exercise price per share of $0.0001. F2 · price: The Warrants are exercisable by the Redmile Funds at any time on or after the original issuance date of the Purchase Agreement until fully exercised at an exercise price per share equal to $0.0001, subject to a 9.99% beneficial ownership blocker. The Warrants have no expiration date. F2 · derivative.exercise_date: The Warrants are exercisable by the Redmile Funds at any time on or after the original issuance date of the Purchase Agreement until fully exercised at an exercise price per share equal to $0.0001, subject to a 9.99% beneficial ownership blocker. The Warrants have no expiration date. F2 · derivative.expiration_date: The Warrants are exercisable by the Redmile Funds at any time on or after the original issuance date of the Purchase Agreement until fully exercised at an exercise price per share equal to $0.0001, subject to a 9.99% beneficial ownership blocker. The Warrants have no expiration date. F3 · ownership.nature: These securities may be deemed beneficially owned by Redmile Group, LLC ("Redmile") as investment manager of the Redmile Funds. The reported securities may also be deemed beneficially owned by Jeremy Green as the principal of Redmile (collectively with Redmile, the "Reporting Persons"). Each of the Reporting Persons disclaims beneficial ownership of the reported securities except to the extent of its or his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Persons are a beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| May 26, 2023 Filed May 31, 2023 16:36 UTC |
Brownstein CarrieDirector
|
GrantStock Option (Right to Buy) · Derivative | 40,258 | $0.00 Strike: $2.72 | $0.00 |
DisclosureSEC source: 0000950170-23-025368 · ownership.xml · derivative · entry 1 Brownstein Carrie · CIK 0001894232 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,258 Underlying: Common Stock · 40,258 shares Expires 2033-05-26 F1 · derivative.exercise_date: This option represents the right to purchase a total of 40,258 shares of the Issuer's common stock, which will vest in full on the earlier of the one-year anniversary of the grant date or immediately prior to the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| May 26, 2023 Filed May 31, 2023 20:43 UTC |
Boudreau Helen MDirector
|
GrantStock Option (Right to Buy) · Derivative | 40,258 | $0.00 Strike: $2.72 | $0.00 |
DisclosureSEC source: 0000950170-23-025380 · ownership.xml · derivative · entry 1 Boudreau Helen M · CIK 0001661481 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,258 Underlying: Common Stock · 40,258 shares Expires 2033-05-26 F1 · derivative.exercise_date: This option represents the right to purchase a total of 40,258 shares of the Issuer's common stock, which will vest in full on the earlier of the one-year anniversary of the grant date or immediately prior to the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| May 26, 2023 Filed May 31, 2023 22:40 UTC |
Redmile Group, LLCDirector · 10% owner
Green JeremyDirector · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 40,258 | $0.00 Strike: $2.72 | $0.00 |
DisclosureSEC source: 0001104659-23-066721 · tm2317377-2_4seq1.xml · derivative · entry 1 Redmile Group, LLC · CIK 0001425738 · Director · 10% owner Green Jeremy · CIK 0001650527 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 40,258 Underlying: Common Stock · 40,258 shares Expires 2033-05-26 F1 · derivative.exercise_date: This option represents a right to purchase a total of 40,258 shares of the Issuer's common stock, which will vest in full on the earlier of the one-year anniversary of the grant date or immediately prior to the next annual meeting of the Issuer's shareholders, subject to Mr. Michael Lee's continued service to the Issuer through such date. F2 · ownership.nature: The stock option was granted to Mr. Lee, a managing director of Redmile Group, LLC ("Redmile"), in connection with his service as a member of the Board of Directors of the Issuer. Pursuant to the policies of Redmile, Mr. Lee holds this stock option as a nominee on behalf, and for the sole benefit, of Redmile and has assigned all economic, pecuniary and voting rights in respect of the stock option to Redmile. Mr. Lee disclaims beneficial ownership of the stock option, and the filing of this Form 4 shall not be deemed an admission that Mr. Lee is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. F3 · ownership.nature: The stock option may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green disclaim beneficial ownership of the stock option except to the extent of their pecuniary interest therein, and this Form 4 shall not be deemed an admission that Redmile or Mr. Green is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. F4 · ownership.nature: Mr. Lee, a member of the board of directors of the Issuer and a managing director of Redmile, was elected to the board of the Issuer as a representative of Redmile. As a result, the Reporting Persons are directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 26, 2023 Filed May 31, 2023 16:39 UTC |
Gibson Neil WDirector
|
GrantStock Option (Right to Buy) · Derivative | 40,258 | $0.00 Strike: $2.72 | $0.00 |
DisclosureSEC source: 0000950170-23-025373 · ownership.xml · derivative · entry 1 Gibson Neil W · CIK 0001555918 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,258 Underlying: Common Stock · 40,258 shares Expires 2033-05-26 F1 · derivative.exercise_date: This option represents the right to purchase a total of 40,258 shares of the Issuer's common stock, which will vest in full on the earlier of the one-year anniversary of the grant date or immediately prior to the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| May 26, 2023 Filed May 31, 2023 20:40 UTC |
Golumbeski GeorgeDirector
|
GrantStock Option (Right to Buy) · Derivative | 40,258 | $0.00 Strike: $2.72 | $0.00 |
DisclosureSEC source: 0000950170-23-025375 · ownership.xml · derivative · entry 1 Golumbeski George · CIK 0001586660 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,258 Underlying: Common Stock · 40,258 shares Expires 2023-05-26 F1 · derivative.exercise_date: This option represents the right to purchase a total of 40,258 shares of the Issuer's common stock, which will vest in full on the earlier of the one-year anniversary of the grant date or immediately prior to the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| May 26, 2023 Filed May 31, 2023 22:39 UTC |
Lee Michael StewartDirector
|
GrantStock Option (Right to Buy) · Derivative | 40,258 | $0.00 Strike: $2.72 | $0.00 |
DisclosureSEC source: 0001104659-23-066719 · tm2317377-1_4seq1.xml · derivative · entry 1 Lee Michael Stewart · CIK 0001748010 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,258 Underlying: Common Stock · 40,258 shares Expires 2033-05-26 F1 · derivative.exercise_date: This option represents a right to purchase a total of 40,258 shares of the Issuer's common stock, which will vest in full on the earlier of (i) the one-year anniversary of the grant date or (ii) immediately prior to the next annual meeting of the Issuer's shareholders, subject to the Reporting Person's continued service to the Issuer through such date. F2 · ownership.direct: The stock option was granted to Mr. Lee in connection with his service as a member of the Board of Directors of the Issuer. Mr. Lee, a managing director of Redmile Group, LLC ("Redmile"), was elected to the board of the Issuer as a representative of Redmile. Pursuant to the policies of Redmile, Mr. Lee holds this stock option as a nominee on behalf, and for the sole benefit, of Redmile and has assigned all economic, pecuniary and voting rights in respect of the stock option to Redmile. Mr. Lee disclaims beneficial ownership of the stock option, and the filing of this Form 4 shall not be deemed an admission that Mr. Lee is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. F3 · ownership.direct: The stock option may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green disclaim beneficial ownership of the stock option except to the extent of their pecuniary interest therein, and this Form 4 shall not be deemed an admission that Redmile or Mr. Green is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. F4 · ownership.direct: Mr. Lee was elected to the board of directors of the Issuer as a representative of Redmile. As a result, Redmile and Mr. Green are directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 26, 2023 Filed May 31, 2023 20:34 UTC |
Brous TylerDirector
|
GrantStock Option (Right to Buy) · Derivative | 40,258 | $0.00 Strike: $2.72 | $0.00 |
DisclosureSEC source: 0000950170-23-025365 · ownership.xml · derivative · entry 1 Brous Tyler · CIK 0001827387 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,258 Underlying: Common Stock · 40,258 shares Expires 2033-05-26 F1 · derivative.exercise_date: This option represents the right to purchase a total of 40,258 shares of the Issuer's common stock, which will vest in full on the earlier of the one-year anniversary of the grant date or immediately prior to the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| May 10, 2023 Filed May 12, 2023 20:11 UTC |
Stout StephenSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 31,800 | $0.00 Strike: $2.79 | $0.00 |
DisclosureSEC source: 0000950170-23-021768 · ownership.xml · derivative · entry 2 Stout Stephen · CIK 0001970664 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,800 Underlying: Common Stock · 31,800 shares Expires 2033-05-10 F2 · derivative.exercise_date: This option represents a right to purchase a total of 31,800 shares of the Issuer's common stock, one quarter of which will vest on May 10, 2024, with the remaining three quarters vesting in equal monthly installments through May 10, 2027, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| May 10, 2023 Filed May 12, 2023 20:11 UTC |
Stout StephenSee Remarks
|
GrantCommon Stock | 15,900 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-021768 · ownership.xml · nonDerivative · entry 1 Stout Stephen · CIK 0001970664 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,875 F1 · shares: Consists of 15,900 restricted stock units, which will vest in four equal annual installments beginning on May 10, 2024, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| January 25, 2023 Filed Jan 27, 2023 23:07 UTC |
Pandite Arundathy N.Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 69,750 | $0.00 Strike: $3.57 | $0.00 |
DisclosureSEC source: 0000899243-23-002884 · doc4.xml · derivative · entry 2 Pandite Arundathy N. · CIK 0001827232 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,750 Underlying: Common Stock · 69,750 shares Expires 2033-01-25 F2 · derivative.exercise_date: This option represents a right to purchase a total of 69,750 shares of the Issuer's common stock, one quarter of which will vest on January 25, 2024, with the remaining three quarters vesting in equal monthly installments through January 25, 2027, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| January 25, 2023 Filed Jan 27, 2023 23:07 UTC |
Pandite Arundathy N.Chief Medical Officer
|
GrantCommon Stock | 37,875 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-002884 · doc4.xml · nonDerivative · entry 1 Pandite Arundathy N. · CIK 0001827232 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,792 F1 · shares: Consists of 37,875 restricted stock units, which will vest in four equal annual installments beginning on January 25, 2024, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| January 25, 2023 Filed Jan 27, 2023 23:04 UTC |
Schreiber TaylorDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 165,050 | $0.00 Strike: $3.57 | $0.00 |
DisclosureSEC source: 0000899243-23-002880 · doc4.xml · derivative · entry 1 Schreiber Taylor · CIK 0001601942 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,050 Underlying: Common Stock · 165,050 shares Expires 2033-01-25 F1 · derivative.exercise_date: This option represents the right to purchase a total of 165,050 shares of the Issuer's common stock, and will vest upon the Issuer's common stock achieving specified share prices during the four years following the grant date, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| January 25, 2023 Filed Jan 27, 2023 18:06 UTC |
DeYoung CasiChief Business Officer
|
GrantStock Option (Right to Buy) · Derivative | 54,200 | $0.00 Strike: $3.57 | $0.00 |
DisclosureSEC source: 0000899243-23-002883 · doc4.xml · derivative · entry 2 DeYoung Casi · CIK 0001652066 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,200 Underlying: Common Stock · 54,200 shares Expires 2033-01-25 F2 · derivative.exercise_date: This option represents a right to purchase a total of 54,200 shares of the Issuer's common stock, one quarter of which will vest on January 25, 2024, with the remaining three quarters vesting in equal monthly installments through January 25, 2027, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| January 25, 2023 Filed Jan 27, 2023 18:06 UTC |
DeYoung CasiChief Business Officer
|
GrantCommon Stock | 27,100 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-002883 · doc4.xml · nonDerivative · entry 1 DeYoung Casi · CIK 0001652066 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,880 F1 · shares: Consists of 27,100 restricted stock units, which will vest in four equal annual installments beginning on January 25, 2024, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| January 25, 2023 Filed Jan 27, 2023 23:13 UTC |
Neill Andrew RChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 69,850 | $0.00 Strike: $3.57 | $0.00 |
DisclosureSEC source: 0000899243-23-002890 · doc4.xml · derivative · entry 2 Neill Andrew R · CIK 0001827204 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,850 Underlying: Common Stock · 69,850 shares Expires 2033-01-25 F2 · derivative.exercise_date: This option represents a right to purchase a total of 69,850 shares of the Issuer's common stock, one quarter of which will vest on January 25, 2024, with the remaining three quarters vesting in equal monthly installments through January 25, 2027, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| January 25, 2023 Filed Jan 27, 2023 23:13 UTC |
Neill Andrew RChief Financial Officer
|
GrantCommon Stock | 34,925 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-002890 · doc4.xml · nonDerivative · entry 1 Neill Andrew R · CIK 0001827204 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,416 F1 · shares: Consists of 34,925 restricted stock units, which will vest in four equal annual installments beginning on January 25, 2024, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| January 25, 2023 Filed Jan 27, 2023 23:11 UTC |
Thomson Erin AtorGeneral Counsel
|
GrantStock Option (Right to Buy) · Derivative | 48,250 | $0.00 Strike: $3.57 | $0.00 |
DisclosureSEC source: 0000899243-23-002889 · doc4.xml · derivative · entry 2 Thomson Erin Ator · CIK 0001827202 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,250 Underlying: Common Stock · 48,250 shares Expires 2033-01-25 F2 · derivative.exercise_date: This option represents a right to purchase a total of 48,250 shares of the Issuer's common stock, one quarter of which will vest on January 25, 2024, with the remaining three quarters vesting in equal monthly installments through January 25, 2027, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| January 25, 2023 Filed Jan 27, 2023 23:11 UTC |
Thomson Erin AtorGeneral Counsel
|
GrantCommon Stock | 24,125 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-002889 · doc4.xml · nonDerivative · entry 1 Thomson Erin Ator · CIK 0001827202 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,209 F1 · shares: Consists of 24,125 restricted stock units, which will vest in four equal annual installments beginning on January 25, 2024, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| January 25, 2023 Filed Jan 27, 2023 23:10 UTC |
Shukla Abhinav A.Chief Technical Officer
|
GrantStock Option (Right to Buy) · Derivative | 52,200 | $0.00 Strike: $3.57 | $0.00 |
DisclosureSEC source: 0000899243-23-002887 · doc4.xml · derivative · entry 2 Shukla Abhinav A. · CIK 0001923377 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,200 Underlying: Common Stock · 52,200 shares Expires 2033-01-25 F2 · derivative.exercise_date: This option represents a right to purchase a total of 52,200 shares of the Issuer's common stock, one quarter of which will vest on January 25, 2024, with the remaining three quarters vesting in equal monthly installments through January 25, 2027, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| January 25, 2023 Filed Jan 27, 2023 23:10 UTC |
Shukla Abhinav A.Chief Technical Officer
|
GrantCommon Stock | 26,100 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-002887 · doc4.xml · nonDerivative · entry 1 Shukla Abhinav A. · CIK 0001923377 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,092 F1 · shares: Consists of 26,100 restricted stock units, which will vest in four equal annual installments beginning on January 25, 2024, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| January 10, 2023 Filed Jan 12, 2023 21:12 UTC |
Pandite Arundathy N.Chief Medical Officer
|
Tax withholdingCommon Stock | 2,987 | $3.03 | $9,050.61 |
DisclosureSEC source: 0000899243-23-001683 · doc4.xml · nonDerivative · entry 1 Pandite Arundathy N. · CIK 0001827232 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,917 Read SEC document |
| January 10, 2023 Filed Jan 12, 2023 16:13 UTC |
DeYoung CasiChief Business Officer
|
Tax withholdingCommon Stock | 1,583 | $3.03 | $4,796.49 |
DisclosureSEC source: 0000899243-23-001684 · doc4.xml · nonDerivative · entry 1 DeYoung Casi · CIK 0001652066 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,780 Read SEC document |
| January 10, 2023 Filed Jan 12, 2023 21:11 UTC |
Shukla Abhinav A.Chief Technical Officer
|
Tax withholdingCommon Stock | 1,933 | $3.03 | $5,856.99 |
DisclosureSEC source: 0000899243-23-001682 · doc4.xml · nonDerivative · entry 1 Shukla Abhinav A. · CIK 0001923377 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,992 F1 · balance_after: Includes 600 shares acquired by the Reporting Person under the Issuer's 2020 Employee Stock Purchase Plan on August 14, 2022. Read SEC document |
| June 08, 2022 Filed Jun 10, 2022 16:31 UTC |
Brownstein CarrieDirector
|
GrantStock Option (Right to Buy) · Derivative | 40,258 | $0.00 Strike: $4.32 | $0.00 |
DisclosureSEC source: 0000899243-22-021924 · doc4.xml · derivative · entry 1 Brownstein Carrie · CIK 0001894232 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,258 Underlying: Common Stock · 40,258 shares Expires 2032-06-08 F1 · derivative.exercise_date: This option represents a right to purchase a total of 40,258 shares of the Issuer's common stock, which will vest in full on the earlier of the one-year anniversary of the grant date or immediately prior to the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 08, 2022 Filed Jun 10, 2022 20:31 UTC |
Boudreau Helen MDirector
|
GrantStock Option (Right to Buy) · Derivative | 40,258 | $0.00 Strike: $4.32 | $0.00 |
DisclosureSEC source: 0000899243-22-021923 · doc4.xml · derivative · entry 1 Boudreau Helen M · CIK 0001661481 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,258 Underlying: Common Stock · 40,258 shares Expires 2032-06-08 F1 · derivative.exercise_date: This option represents a right to purchase a total of 40,258 shares of the Issuer's common stock, which will vest in full on the earlier of the one-year anniversary of the grant date or immediately prior to the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 08, 2022 Filed Jun 11, 2022 01:32 UTC |
Redmile Group, LLCDirector · 10% owner
Green JeremyDirector
|
GrantStock Option (Right to Buy) · Derivative | 40,258 | $0.00 Strike: $4.32 | $0.00 |
DisclosureSEC source: 0001104659-22-070289 · tm2218131-2_4.xml · derivative · entry 1 Redmile Group, LLC · CIK 0001425738 · Director · 10% owner Green Jeremy · CIK 0001650527 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 40,258 Underlying: Common Stock · 40,258 shares Expires 2032-06-08 F1 · derivative.exercise_date: ) This option represents a right to purchase a total of 40,258 shares of the Issuer's common stock, which will vest in full on the earlier of the one-year anniversary of the grant date or immediately prior to the next annual meeting of the Issuer's shareholders, subject to Mr. Michael Lee's continued service to the Issuer through such date. F2 · ownership.nature: The stock option was granted to Mr. Lee, a managing director of Redmile Group, LLC ("Redmile"), in connection with his service as a member of the Board of Directors of the Issuer. Pursuant to the policies of Redmile, Mr. Lee holds this stock option as a nominee on behalf, and for the sole benefit, of Redmile and has assigned all economic, pecuniary and voting rights in respect of the stock option to Redmile. Mr. Lee disclaims beneficial ownership of the stock option, and the filing of this Form 4 shall not be deemed an admission that Mr. Lee is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. F3 · ownership.nature: The stock option may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green disclaim beneficial ownership of the stock option except to the extent of their pecuniary interest therein, and this Form 4 shall not be deemed an admission that Redmile or Mr. Green is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. F4 · ownership.nature: Mr. Lee, a member of the board of directors of the Issuer and a managing director of Redmile, was elected to the board of the Issuer as a representative of Redmile. As a result, the Reporting Persons are directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| June 08, 2022 Filed Jun 10, 2022 16:31 UTC |
Gibson Neil WDirector
|
GrantStock Option (Right to Buy) · Derivative | 40,258 | $0.00 Strike: $4.32 | $0.00 |
DisclosureSEC source: 0000899243-22-021922 · doc4.xml · derivative · entry 1 Gibson Neil W · CIK 0001555918 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,258 Underlying: Common Stock · 40,258 shares Expires 2032-06-08 F1 · derivative.exercise_date: This option represents a right to purchase a total of 40,258 shares of the Issuer's common stock, which will vest in full on the earlier of the one-year anniversary of the grant date or immediately prior to the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 08, 2022 Filed Jun 10, 2022 20:30 UTC |
Golumbeski GeorgeDirector
|
GrantStock Option (Right to Buy) · Derivative | 40,258 | $0.00 Strike: $4.32 | $0.00 |
DisclosureSEC source: 0000899243-22-021918 · doc4.xml · derivative · entry 1 Golumbeski George · CIK 0001586660 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,258 Underlying: Common Stock · 40,258 shares Expires 2032-06-08 F1 · derivative.exercise_date: This option represents a right to purchase a total of 40,258 shares of the Issuer's common stock, which will vest in full on the earlier of the one-year anniversary of the grant date or immediately prior to the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 08, 2022 Filed Jun 11, 2022 01:30 UTC |
Lee Michael StewartDirector
|
GrantStock Option (Right to Buy) · Derivative | 40,258 | $0.00 Strike: $4.32 | $0.00 |
DisclosureSEC source: 0001104659-22-070287 · tm2218131-1_4.xml · derivative · entry 1 Lee Michael Stewart · CIK 0001748010 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,258 Underlying: Common Stock · 40,258 shares Expires 2032-06-08 F1 · derivative.exercise_date: This option represents a right to purchase a total of 40,258 shares of the Issuer's common stock, which will vest in full on the earlier of (i) the one-year anniversary of the grant date or (ii) immediately prior to the next annual meeting of the Issuer's shareholders, subject to the Reporting Person's continued service to the Issuer through such date. F2 · ownership.direct: The stock option was granted to Mr. Lee in connection with his service as a member of the Board of Directors of the Issuer. Mr. Lee, a managing director of Redmile Group, LLC ("Redmile"), was elected to the board of the Issuer as a representative of Redmile. Pursuant to the policies of Redmile, Mr. Lee holds this stock option as a nominee on behalf, and for the sole benefit, of Redmile and has assigned all economic, pecuniary and voting rights in respect of the stock option to Redmile. Mr. Lee disclaims beneficial ownership of the stock option, and the filing of this Form 4 shall not be deemed an admission that Mr. Lee is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. F3 · ownership.direct: The stock option may also be deemed beneficially owned by Jeremy Green as the principal of Redmile. Redmile and Mr. Green disclaim beneficial ownership of the stock option except to the extent of their pecuniary interest therein, and this Form 4 shall not be deemed an admission that Redmile or Mr. Green is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. F4 · ownership.direct: Mr. Lee was elected to the board of directors of the Issuer as a representative of Redmile. As a result, Redmile and Mr. Green are directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| June 08, 2022 Filed Jun 10, 2022 20:31 UTC |
Brous TylerDirector
|
GrantStock Option (Right to Buy) · Derivative | 40,258 | $0.00 Strike: $4.32 | $0.00 |
DisclosureSEC source: 0000899243-22-021928 · doc4.xml · derivative · entry 1 Brous Tyler · CIK 0001827387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,258 Underlying: Common Stock · 40,258 shares Expires 2032-06-08 F1 · derivative.exercise_date: This option represents a right to purchase a total of 40,258 shares of the Issuer's common stock, which will vest in full on the earlier of the one-year anniversary of the grant date or immediately prior to the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| April 26, 2022 Filed Apr 27, 2022 20:05 UTC |
Golumbeski GeorgeDirector
|
PurchaseCommon Stock | 28,330 | $3.63 | $102,837.90 |
DisclosureSEC source: 0000899243-22-015764 · doc4.xml · nonDerivative · entry 1 Golumbeski George · CIK 0001586660 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,613 F1 · price: This transaction was executed in multiple trades at prices ranging from $3.505 to $3.78. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 22, 2022 Filed Apr 26, 2022 16:26 UTC |
Golumbeski GeorgeDirector
|
PurchaseCommon Stock | 234 | $3.67 | $858.78 |
DisclosureSEC source: 0000899243-22-015609 · doc4.xml · nonDerivative · entry 2 Golumbeski George · CIK 0001586660 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,283 Read SEC document |
| April 21, 2022 Filed Apr 26, 2022 16:26 UTC |
Golumbeski GeorgeDirector
|
PurchaseCommon Stock | 26,049 | $3.69 | $96,120.81 |
DisclosureSEC source: 0000899243-22-015609 · doc4.xml · nonDerivative · entry 1 Golumbeski George · CIK 0001586660 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,049 F1 · price: This transaction was executed in multiple trades at prices ranging from $3.62 to $3.80. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 28, 2022 Filed Jan 31, 2022 21:38 UTC |
Schreiber TaylorDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,926 | $0.00 Strike: $4.67 | $0.00 |
DisclosureSEC source: 0000899243-22-003671 · doc4.xml · derivative · entry 3 Schreiber Taylor · CIK 0001601942 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,597 Underlying: Common Stock · 3,926 shares Expires 2030-08-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option represents the right to purchase a total of 188,375 shares of the Issuer's common stock, one quarter of which vested on August 6, 2021, with the remaining three quarters vesting in equal monthly installments through August 6, 2024, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| January 28, 2022 Filed Jan 31, 2022 21:38 UTC |
Schreiber TaylorDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 3,926 | $4.67 | $18,334.42 |
DisclosureSEC source: 0000899243-22-003671 · doc4.xml · nonDerivative · entry 1 Schreiber Taylor · CIK 0001601942 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,052 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 19, 2022 Filed Jan 20, 2022 00:20 UTC |
Brous TylerDirector
|
PurchaseCommon Stock | 3,000 | $6.87 | $20,610.00 |
DisclosureSEC source: 0000899243-22-002496 · doc4.xml · nonDerivative · entry 3 Brous Tyler · CIK 0001827387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,672 Read SEC document |
| January 18, 2022 Filed Jan 20, 2022 00:20 UTC |
Brous TylerDirector
|
PurchaseCommon Stock | 2,500 | $7.01 | $17,525.00 |
DisclosureSEC source: 0000899243-22-002496 · doc4.xml · nonDerivative · entry 2 Brous Tyler · CIK 0001827387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,672 Read SEC document |
| January 14, 2022 Filed Jan 20, 2022 00:20 UTC |
Brous TylerDirector
|
PurchaseCommon Stock | 2,500 | $7.16 | $17,900.00 |
DisclosureSEC source: 0000899243-22-002496 · doc4.xml · nonDerivative · entry 1 Brous Tyler · CIK 0001827387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,172 Read SEC document |
| January 12, 2022 Filed Jan 12, 2022 23:39 UTC |
Thomson Erin AtorGeneral Counsel
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $2.95 | $0.00 |
DisclosureSEC source: 0000899243-22-001791 · doc4.xml · derivative · entry 4 Thomson Erin Ator · CIK 0001827202 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,705 Underlying: Common Stock · 10,000 shares Expires 2028-09-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option represents the right to purchase a total of 63,705 shares of the Issuer's common stock, 15,925 of which vested on May 15, 2019, with the remaining shares vesting in equal monthly installments through May 15, 2022. Read SEC document |
| January 12, 2022 Filed Jan 12, 2022 23:39 UTC |
Thomson Erin AtorGeneral Counsel
|
Exercise / conversionCommon Stock | 10,000 | $2.95 | $29,500.00 |
DisclosureSEC source: 0000899243-22-001791 · doc4.xml · nonDerivative · entry 2 Thomson Erin Ator · CIK 0001827202 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,084 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 10, 2022 Filed Jan 12, 2022 23:45 UTC |
Pandite Arundathy N.Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 69,475 | $0.00 Strike: $7.43 | $0.00 |
DisclosureSEC source: 0000899243-22-001797 · doc4.xml · derivative · entry 2 Pandite Arundathy N. · CIK 0001827232 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,475 Underlying: Common Stock · 69,475 shares Expires 2032-01-10 F2 · derivative.exercise_date: This option represented a right to purchase a total of 69,475 shares of the Issuer's common stock, one quarter of which will vest on January 10, 2023, with the remaining three quarters vesting in equal monthly installments through January 10, 2026, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| January 10, 2022 Filed Jan 12, 2022 23:45 UTC |
Pandite Arundathy N.Chief Medical Officer
|
GrantCommon Stock | 34,738 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-001797 · doc4.xml · nonDerivative · entry 1 Pandite Arundathy N. · CIK 0001827232 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,904 F1 · shares: Consists of 34,738 restricted stock units, which will vest in four equal annual installments beginning on January 10, 2023, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| January 10, 2022 Filed Jan 12, 2022 23:39 UTC |
Schreiber TaylorDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 178,150 | $0.00 Strike: $7.43 | $0.00 |
DisclosureSEC source: 0000899243-22-001790 · doc4.xml · derivative · entry 1 Schreiber Taylor · CIK 0001601942 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,150 Underlying: Common Stock · 178,150 shares Expires 2032-01-10 F1 · derivative.exercise_date: This option represents the right to purchase a total of 178,150 shares of the Issuer's common stock, and will vest upon the Issuer's common stock achieving a specified price per share, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.